Their results suggest that ADAMTS2 plays a key role in modulating the expression of other heart failure-related genes (including natriuretic peptide A (Nppa) and natriuretic peptide B (Nppb)) in response to isoproterenol treatment. The gene discussed is NPPA; the disease is heart failure.